Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2020 / N 2

Возможности ангиопротекции у пациентов с артериальной гипертонией и бессимптомной гиперурикемией при терапии аллопуринолом
С.В. Недогода, Т.Н. Санина, В.В. Цома, А.А. Ледяева, Е.В. Чумачек, А.С. Саласюк, Д.С. Власов

Список литературы

1. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Archives of Internal Medicine 2009 Feb;169(4):342-50.
2. Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R. Elevated uric acid increases the risk for kidney disease. Journal of the American Society of Nephrology 2008 Dec;19(12):2407-13.
3. Oda E, Kawai R, Sukumaran V, Watanabe K. Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Internal Medicine 2009;48(20):1785-91.
4. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal 2018;00:1-98.
5. Российское кардиологическое общество. Клинические рекомендации. Артериальная гипертензия у взрослых. Коды по МКБ 10: I10/ I11/ I12/ I13/ I15. Возрастная группа: взрослые. Год утверждения: 2020. М., 2020. 136 с. Доступно по: https://scardio.ru/content/Guidelines/Clinic_rek_AG_2020.pdf Ссылка активна на 09.10.2020.
6. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension (Dallas, Tex.: 1979) 2003 Jun;41(6):1183-90.
7. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. A causal role for uric acid in fructose-induced metabolic syndrome. American Journal of Physiology. Renal Physiology 2006 Mar;290(3):F625-31.
8. See LC, Kuo CF, Chuang FH, Shen YM, Ko YS, Chen YM, Yu KH. Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. Clinical Rheumatology 2011 Mar;30(3):323-30.
9. Chen LY, Zhu WH, Chen Z, Dai HL, Ren JJ, Chen JH, Chen LG, Fang LZ. Relationship between hyperuricemia and metabolic syndrome. Journal of Zhejiang University Science B 2007 Aug;8(8):593-8.
10. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004 Mar;4:9-15.
11. Prado de Oliveira E, Moreto F, de Arruda Silveira LV, Burini RC. Dietary, anthropometric, and biochemical determinants of uric acid in free-living adults. Nutrition Journal 2013 Jan;12:11.
12. Iwashima Y, Horio Т, Kamide К, Rakugi H, Ogihara T, Kawano Y. Uric acid, left ventricular mass index and risk of cardiovascular disease in essential hypertension. Hypertension (Dallas, Tex.: 1979) 2006 Feb;47(2):195-202.
13. Mitsuhashi H, Yatsuya H, Matsushita K, Zhang H, Otsuka R, Muramatsu T, Takefuji S, Hotta Y, Kondo T, Murohara T, Toyoshima H, Tamakoshi K. Uric acid and left ventricular hypertrophy in Japanese men. Circulation Journal 2009 Apr;73(4):667-72.
14. Cuspidi C, Valerio C, Sala C, Meani S, Esposito A, Zanchetti A, Mancia G. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. American Journal of Hypertension 2007 Jun;20(6):678-85.
15. Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, Ratto E, Vettoretti S, Bezante GP, Del Sette M, Deferrari G, Pontremoli R. Serum uric acid and target organ damage in primary hypertension. Hypertension (Dallas, Tex.: 1979) 2005 May;45(5):991-8.
16. Campo C, Ruilope LM, Segura J, Rodicio JL, García-Robles R, Garcia-Puig J. Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension. Blood Pressure 2003;12(5-6):277-83.
17. Kawamoto R, Tomita H, Oka Y, Ohtsuka N. Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Internal Medicine 2006;45(9):605-14.
18. Vlachopoulos C, Xaplanteris P, Vyssoulis G, Bratsas A, Baou K, Tzamou V, Aznaouridis K, Dima I, Lazaros G, Stefanadis G. Association of serum uric acid level with aortic stiffness and arterial wave reflections in newly diagnosed, never-treated hypertension. American Journal of Hypertension 2011 Jan;24(1):33-9.
19. Tsai WC, Huang YY, Lin CC, Li WT, Lee CH, Chen JY, Chen JH. Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Heart and Vessels 2009 Sep;24(5):371-5.
20. Choi HK, Soriano LC, Zhang Y, García Rodríguez LA. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ 2012 Jan;344:d8190.
21. Hoieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahlöf B; LIFE Study Group. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney International 2004 Mar;65(3):1041-9.
22. Doupis J, Papanas N, Cohen A, McFarlan L, Horton E. Pulse wave analysis by applanation tonometry for the measurement of arterial stiffness. The Open Cardiovascular Medicine Journal 2016 Aug;10:188-95.
23. Van Bortel LM, De Backer T, Segers P. Standardization of arterial stiffness measurements make them ready for use in clinical practice. American Journal of Hypertension 2016 Nov;29(11):1234-6.
24. Luk AJ, Levin GP, Moore EE, Zhou XH, Kestenbaum BR, Choi HK. Allopurinol and mortality in hyperuricaemic patients. Rheumatology (Oxford, England) 2009 Jul;7:804-6.
25. Goicoechea M, García de Vinuesa S, Verdalles U, Ruiz-Caro C, Ampuero J, Rincón A, Arroyo D, Luño J. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clinical Journal of the American Society of Nephrology 2010 Aug;5(8):1388-93.
26. Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akcay A, Yigitoglu R, Covic A. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. International Urology and Nephrology 2007;39(4):1227-33.
27. Kato M, Hisatome I, Tomikura Y, Kotani K, Kinugawa T, Ogino K, Ishida K, Igawa O, Shigemasa C, Somers VK. Status of endothelial dependent vasodilation in patients with hyperuricemia. American Journal of Cardioliogy 2005 Dec;95(11):1576-80.
28. Kanbay M, Huddam B, Azak A, Solak Y, Kocak Kadioglu GK, Kirbas I, Duranay M, Covic A, Johnson RJ. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clinical Journal of the American Society of Nephrology 2011 Aug;6(8):1887-94.
29. Kostka-Jeziorny K, Uruski P, Tykarski A. Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients. Blood Pressure 2011 Apr;20(2):104-10.
30. Feig D, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008 Aug;300(8):924-32.
31. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. American Journal of Kidney Diseases 2006 Jan;47(1):51-9.

References

1. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Archives of Internal Medicine 2009 Feb;169(4):342-50.
2. Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R. Elevated uric acid increases the risk for kidney disease. Journal of the American Society of Nephrology 2008 Dec;19(12):2407-13.
3. Oda E, Kawai R, Sukumaran V, Watanabe K. Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Internal Medicine 2009;48(20):1785-91.
4. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European Heart Journal 2018;00:1-98.
5. Russian Society of Cardiology. Clinical recommendations. Arterial hypertension in adults. ICD 10 codes: I10/ I11/ I12/ I13/ I15. Age group: adults. Year of approval: 2020. Moscow, 2020. 136 p. Available from: https://scardio.ru/content/Guidelines/Clinic_rek_AG_2020.pdf Accessed 2020 Oct 09. (In Russian).
6. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension (Dallas, Tex.: 1979) 2003 Jun;41(6):1183-90.
7. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. A causal role for uric acid in fructose-induced metabolic syndrome. American Journal of Physiology. Renal Physiology 2006 Mar;290(3):F625-31.
8. See LC, Kuo CF, Chuang FH, Shen YM, Ko YS, Chen YM, Yu KH. Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. Clinical Rheumatology 2011 Mar;30(3):323-30.
9. Chen LY, Zhu WH, Chen Z, Dai HL, Ren JJ, Chen JH, Chen LG, Fang LZ. Relationship between hyperuricemia and metabolic syndrome. Journal of Zhejiang University Science B 2007 Aug;8(8):593-8.
10. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004 Mar;4:9-15.
11. Prado de Oliveira E, Moreto F, de Arruda Silveira LV, Burini RC. Dietary, anthropometric, and biochemical determinants of uric acid in free-living adults. Nutrition Journal 2013 Jan;12:11.
12. Iwashima Y, Horio Т, Kamide К, Rakugi H, Ogihara T, Kawano Y. Uric acid, left ventricular mass index and risk of cardiovascular disease in essential hypertension. Hypertension (Dallas, Tex.: 1979) 2006 Feb;47(2):195-202.
13. Mitsuhashi H, Yatsuya H, Matsushita K, Zhang H, Otsuka R, Muramatsu T, Takefuji S, Hotta Y, Kondo T, Murohara T, Toyoshima H, Tamakoshi K. Uric acid and left ventricular hypertrophy in Japanese men. Circulation Journal 2009 Apr;73(4):667-72.
14. Cuspidi C, Valerio C, Sala C, Meani S, Esposito A, Zanchetti A, Mancia G. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. American Journal of Hypertension 2007 Jun;20(6):678-85.
15. Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, Ratto E, Vettoretti S, Bezante GP, Del Sette M, Deferrari G, Pontremoli R. Serum uric acid and target organ damage in primary hypertension. Hypertension (Dallas, Tex.: 1979) 2005 May;45(5):991-8.
16. Campo C, Ruilope LM, Segura J, Rodicio JL, García-Robles R, Garcia-Puig J. Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension. Blood Pressure 2003;12(5-6):277-83.
17. Kawamoto R, Tomita H, Oka Y, Ohtsuka N. Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Internal Medicine 2006;45(9):605-14.
18. Vlachopoulos C, Xaplanteris P, Vyssoulis G, Bratsas A, Baou K, Tzamou V, Aznaouridis K, Dima I, Lazaros G, Stefanadis G. Association of serum uric acid level with aortic stiffness and arterial wave reflections in newly diagnosed, never-treated hypertension. American Journal of Hypertension 2011 Jan;24(1):33-9.
19. Tsai WC, Huang YY, Lin CC, Li WT, Lee CH, Chen JY, Chen JH. Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Heart and Vessels 2009 Sep;24(5):371-5.
20. Choi HK, Soriano LC, Zhang Y, García Rodríguez LA. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ 2012 Jan;344:d8190.
21. Hoieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahlöf B; LIFE Study Group. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney International 2004 Mar;65(3):1041-9.
22. Doupis J, Papanas N, Cohen A, McFarlan L, Horton E. Pulse wave analysis by applanation tonometry for the measurement of arterial stiffness. The Open Cardiovascular Medicine Journal 2016 Aug;10:188-95.
23. Van Bortel LM, De Backer T, Segers P. Standardization of arterial stiffness measurements make them ready for use in clinical practice. American Journal of Hypertension 2016 Nov;29(11):1234-6.
24. Luk AJ, Levin GP, Moore EE, Zhou XH, Kestenbaum BR, Choi HK. Allopurinol and mortality in hyperuricaemic patients. Rheumatology (Oxford, England) 2009 Jul;7:804-6.
25. Goicoechea M, García de Vinuesa S, Verdalles U, Ruiz-Caro C, Ampuero J, Rincón A, Arroyo D, Luño J. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clinical Journal of the American Society of Nephrology 2010 Aug;5(8):1388-93.
26. Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akcay A, Yigitoglu R, Covic A. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. International Urology and Nephrology 2007;39(4):1227-33.
27. Kato M, Hisatome I, Tomikura Y, Kotani K, Kinugawa T, Ogino K, Ishida K, Igawa O, Shigemasa C, Somers VK. Status of endothelial dependent vasodilation in patients with hyperuricemia. American Journal of Cardioliogy 2005 Dec;95(11):1576-80.
28. Kanbay M, Huddam B, Azak A, Solak Y, Kocak Kadioglu GK, Kirbas I, Duranay M, Covic A, Johnson RJ. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clinical Journal of the American Society of Nephrology 2011 Aug;6(8):1887-94.
29. Kostka-Jeziorny K, Uruski P, Tykarski A. Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients. Blood Pressure 2011 Apr;20(2):104-10.
30. Feig D, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008 Aug;300(8):924-32.
31. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. American Journal of Kidney Diseases 2006 Jan;47(1):51-9.
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]